Market Cap 340.89M
Revenue (ttm) 9.50M
Net Income (ttm) -18.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -195.89%
Debt to Equity Ratio 0.00
Volume 2,294,000
Avg Vol 1,233,760
Day's Range N/A - N/A
Shares Out 230.33M
Stochastic %K 100%
Beta 1.74
Analysts Strong Sell
Price Target $4.17

Company Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the tre...

Industry: Biotechnology
Sector: Healthcare
Phone: 442 287 8990
Address:
2173 Salk Avenue, Suite 200, Carlsbad, United States
JohnPDaly
JohnPDaly Feb. 3 at 9:27 PM
$LCTX Stop thinking of this as a stock and think of it as a business and you won’t consider selling your interest now. Steady Lads.
1 · Reply
ChasRiggs
ChasRiggs Feb. 3 at 9:14 PM
$LCTX good day when calls are selling.
0 · Reply
jackedmund99
jackedmund99 Feb. 3 at 9:08 PM
$LCTX so I found a piece of News. I don’t know if anybody else knew about it but there’s a firm called. Rrfintiv:Verud yesterday late in the day they upgraded the stock from SELL to hold - who the fuck are these assholes? Maybe that’s why they drove the stock down so they could cover their position. There’s a lot of manipulation is one thing that’s not manipulated is the insiders that import the stock in the institution that a state constant and continues to increase.
1 · Reply
jackedmund99
jackedmund99 Feb. 3 at 9:01 PM
$LCTX 35,000 shares on the close at 1.76  it’s been a long time since the stock closed on strength at the high of the day. Somethings gotta be going on.
2 · Reply
requiem13
requiem13 Feb. 3 at 9:01 PM
$LCTX It held…
0 · Reply
Invest2live
Invest2live Feb. 3 at 8:59 PM
$LCTX 40% already; congrats 🎈 🌿🎈 $AKBA and $GERN; excellent value
0 · Reply
Wawawiiwa
Wawawiiwa Feb. 3 at 8:19 PM
$LCTX strong day!
0 · Reply
Cooshie
Cooshie Feb. 3 at 7:57 PM
$LCTX short position as of 1/15/26 25,100,000
1 · Reply
jackedmund99
jackedmund99 Feb. 3 at 7:46 PM
$LCTX anyone know what the short position is right now?
1 · Reply
WaveyMaybeDavey
WaveyMaybeDavey Feb. 3 at 7:39 PM
$LCTX BC, hypo-immune cells…”could really be applicable to something like diabetes.”
1 · Reply
Latest News on LCTX
Lineage Cell Therapeutics Issues Letter to Stockholders

Jan 5, 2026, 8:00 AM EST - 4 weeks ago

Lineage Cell Therapeutics Issues Letter to Stockholders


Two Biotech Stocks Poised For Big Moves On Monday

Jun 23, 2025, 7:39 AM EDT - 8 months ago

Two Biotech Stocks Poised For Big Moves On Monday

SANA


Lineage to Present at 2024 BIO International Convention

May 30, 2024, 8:00 AM EDT - 1 year ago

Lineage to Present at 2024 BIO International Convention


JohnPDaly
JohnPDaly Feb. 3 at 9:27 PM
$LCTX Stop thinking of this as a stock and think of it as a business and you won’t consider selling your interest now. Steady Lads.
1 · Reply
ChasRiggs
ChasRiggs Feb. 3 at 9:14 PM
$LCTX good day when calls are selling.
0 · Reply
jackedmund99
jackedmund99 Feb. 3 at 9:08 PM
$LCTX so I found a piece of News. I don’t know if anybody else knew about it but there’s a firm called. Rrfintiv:Verud yesterday late in the day they upgraded the stock from SELL to hold - who the fuck are these assholes? Maybe that’s why they drove the stock down so they could cover their position. There’s a lot of manipulation is one thing that’s not manipulated is the insiders that import the stock in the institution that a state constant and continues to increase.
1 · Reply
jackedmund99
jackedmund99 Feb. 3 at 9:01 PM
$LCTX 35,000 shares on the close at 1.76  it’s been a long time since the stock closed on strength at the high of the day. Somethings gotta be going on.
2 · Reply
requiem13
requiem13 Feb. 3 at 9:01 PM
$LCTX It held…
0 · Reply
Invest2live
Invest2live Feb. 3 at 8:59 PM
$LCTX 40% already; congrats 🎈 🌿🎈 $AKBA and $GERN; excellent value
0 · Reply
Wawawiiwa
Wawawiiwa Feb. 3 at 8:19 PM
$LCTX strong day!
0 · Reply
Cooshie
Cooshie Feb. 3 at 7:57 PM
$LCTX short position as of 1/15/26 25,100,000
1 · Reply
jackedmund99
jackedmund99 Feb. 3 at 7:46 PM
$LCTX anyone know what the short position is right now?
1 · Reply
WaveyMaybeDavey
WaveyMaybeDavey Feb. 3 at 7:39 PM
$LCTX BC, hypo-immune cells…”could really be applicable to something like diabetes.”
1 · Reply
Mikeynumbers
Mikeynumbers Feb. 3 at 7:03 PM
$LCTX Crypto and AI dies but cures for eyes flies.
0 · Reply
pThebee
pThebee Feb. 3 at 6:57 PM
$LCTX what's the conclusion on up 20 cents on only 1 million shares in crappy red tape market that is rolling over throughout the day? we had day where we didn't move a penny on 2 million shares
1 · Reply
Special_Elvis
Special_Elvis Feb. 3 at 6:29 PM
$LCTX I love when the stock goes up, but we've seen these moves before. I want some juicy news!
3 · Reply
Ablidy
Ablidy Feb. 3 at 6:21 PM
$LCTX a bout time
0 · Reply
GrumpyBull_747
GrumpyBull_747 Feb. 3 at 6:21 PM
$LCTX No comment.
0 · Reply
pThebee
pThebee Feb. 3 at 6:18 PM
$LCTX now most important is the close! especially in market red tape. nail the landing!
0 · Reply
ironhide
ironhide Feb. 3 at 6:15 PM
$LCTX whats this about?
1 · Reply
redbugs
redbugs Feb. 3 at 6:09 PM
$LCTX Why the share price increase today? Anyone?
2 · Reply
Ablidy
Ablidy Feb. 3 at 6:08 PM
$LCTX **🌟 A Timeless Bridge: From the 1990 Jackson-Blidy Discovery to Today’s Hypoimmune Breakthroughs in Immune Tolerance 🌟** Back in 1990, Anne Jackson and Andy Blidy (Becton Dickinson) used the new FACScan with PE-conjugated antibodies to show restricted expression of the p55 IL-2 receptor (CD25) on human CD4+ T cells. Their work was one of the earliest clear visualizations of what we now know as the **CD4+CD25+ regulatory T cell (Treg)** population — the natural guardians of immune self-tolerance. Fast-forward to January 6, 2026: **Lineage Cell Therapeutics (LCTX)** announced receipt of a proprietary gene-edited **hypoimmune iPSC line** developed by **Factor Bioscience**. This line is engineered for true “off-the-shelf” allogeneic use: - **B2M knockout** → eliminates surface MHC class I → evades CD8+ T-cell killing - **HLA-E overexpression** → inhibits NK-cell attack - Additional undisclosed edit (likely CIITA knockout) → removes MHC class II → disrupts CD4+ T-cell
1 · Reply
jackedmund99
jackedmund99 Feb. 3 at 5:58 PM
$LCTX look, we shouldn’t get hung up about the price of the stock no matter what it does. The only thing we need to concern ourselves with is how much cash they still have in the bank who’s funding them who’s doing partnerships with them and how well the science is progressing if if it continues as we expect we’re talking about a multi billion dollar company and all the nice areas can go fuck themselves. Could this be a 1520 $30 stock? Why not if artificial intelligence can’t make any money and they could have trillion dollar evaluations what happens when Genentech roach turns their artificial intelligence quantum computer loose on what we have doing here we’re talking about a change in medicine as we know it enjoy sit back relax Cell on strength by on weakness
1 · Reply
pThebee
pThebee Feb. 3 at 5:53 PM
$LCTX sit back and experience the "they" effect!
0 · Reply
Migane
Migane Feb. 3 at 5:47 PM
$LCTX this year… :)
0 · Reply